日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.

可溶性程序性死亡配体 1 作为接受纳武利尤单抗、帕博利珠单抗或阿特珠单抗治疗的非小细胞肺癌患者的预后生物标志物

Brun Sinne Søberg, Hansen Torben Frøstrup, Wen Sara Witting Christensen, Nyhus Christa Haugaard, Bertelsen Lisbeth, Jakobsen Anders, Hansen Torben Schjødt, Nederby Line

Mutations in BCOR, a co-repressor of CRX/OTX2, are associated with early-onset retinal degeneration

BCOR(CRX/OTX2 的共抑制因子)的突变与早发性视网膜变性相关。

Maéva Langouët,Christine Jolicoeur,Awais Javed,Pierre Mattar,Micah D Gearhart,Stephen P Daiger,Mette Bertelsen,Lisbeth Tranebjærg,Nanna D Rendtorff,Karen Grønskov,Catherine Jespersgaard,Rui Chen,Zixi Sun,Hui Li,Najmeh Alirezaie,Jacek Majewski,Vivian J Bardwell,Ruifang Sui,Robert K Koenekoop,Michel Cayouette

Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study

口服避孕药和绝经后激素与BRCA1和BRCA2基因突变携带者和非携带者对侧乳腺癌风险的关系:WECARE研究

Figueiredo, Jane C; Haile, Robert W; Bernstein, Leslie; Malone, Kathleen E; Largent, Joan; Langholz, Bryan; Lynch, Charles F; Bertelsen, Lisbeth; Capanu, Marinela; Concannon, Patrick; Borg, Ake; Børresen-Dale, Anne-Lise; Diep, Anh; Teraoka, Sharon; Torngren, Therese; Xue, Shanyan; Bernstein, Jonine L

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

一项基于人群的研究探讨了BRCA1/BRCA2基因突变携带者乳腺癌辅助全身治疗对侧乳腺癌风险的影响

Reding, Kerryn W; Bernstein, Jonine L; Langholz, Bryan M; Bernstein, Leslie; Haile, Robert W; Begg, Colin B; Lynch, Charles F; Concannon, Patrick; Borg, Ake; Teraoka, Sharon N; Törngren, Therese; Diep, Anh; Xue, Shanyan; Bertelsen, Lisbeth; Liang, Xiaolin; Reiner, Anne S; Capanu, Marinela; Malone, Kathleen E